NSC228155

CAS No. 113104-25-9

NSC228155( NSC228155 | NSC-228155 )

Catalog No. M17832 CAS No. 113104-25-9

NSC228155 is an activator of EGFR, binding to the sEGFR dimerization domain II and modulate EGFR tyrosine phosphorylation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 39 In Stock
10MG 55 In Stock
25MG 114 In Stock
50MG 208 In Stock
100MG 361 In Stock
200MG 469 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NSC228155
  • Note
    Research use only, not for human use.
  • Brief Description
    NSC228155 is an activator of EGFR, binding to the sEGFR dimerization domain II and modulate EGFR tyrosine phosphorylation.
  • Description
    NSC228155 is an inhibitor of KIX-KID interaction that acts by enhancing tyrosine phosphorylation of EGFR.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC228155 | NSC-228155
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    KIX-KID interaction| EGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    113104-25-9
  • Formula Weight
    290.25
  • Molecular Formula
    C11H6N4O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 16 mg/mL 55.12 mM;H2O : < 0.1 mg/mL
  • SMILES
    C1=CC=[N+](C(=C1)SC2=CC=C(C3=NON=C23)[N+](=O)[O-])[O-]
  • Chemical Name
    2-[(7-Nitrobenzo[c][1,2,5]oxadiazol-4-yl)thio]pyridine 1-oxide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (2E,2E)-Upenazime

    Upenazime is a non-radioactive precursor agent for diagnostic imaging.

  • Longistylin C

    Longistylin A and longistylin C show some cytotoxic effects, with IC(50) values of 0.7-14.7 microM against the range of cancer cell lines.

  • pep2-AVKI

    Inhibitor peptide that selectively disrupts binding of the AMPA receptor subunit GluA2 (at the C-terminal PDZ site) to protein interacting with C kinase (PICK1). Does not affect binding of GluA2 to GRIP or ABP and does not increase AMPA current amplitude or affect long term depression (LTD).